Literature DB >> 1326407

The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites.

C Cerami1, U Frevert, P Sinnis, B Takacs, P Clavijo, M J Santos, V Nussenzweig.   

Abstract

Minutes after injection into the circulation, malaria sporozoites enter hepatocytes. The speed and specificity of the invasion process suggest that it is receptor mediated. We show here that recombinant Plasmodium falciparum circumsporozoite protein (CS) binds specifically to regions of the plasma membrane of hepatocytes exposed to circulating blood in the Disse space. No binding has been detected in other organs, or even in other regions of the hepatocyte membrane. The interaction of CS with hepatocytes, as well as sporozoite invasion of HepG2 cells, is inhibited by synthetic peptides representing the evolutionarily conserved region II of CS. We conclude that region II is a sporozoite ligand for hepatocyte receptors localized to the basolateral domain of the plasma membrane. Our findings provide a rational explanation for the target cell specificity of malaria sporozoites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326407     DOI: 10.1016/0092-8674(92)90251-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  113 in total

1.  The cytotoxic T-lymphocyte epitope of the Plasmodium falciparum circumsporozoite protein also modulates the efficiency of receptor-ligand interaction with hepatocytes.

Authors:  D Rathore; T F McCutchan
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin.

Authors:  Odile Cérède; Jean François Dubremetz; Daniel Bout; Maryse Lebrun
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

3.  The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for plasmodium sporozoite attachment to target cells.

Authors:  C Pinzon-Ortiz; J Friedman; J Esko; P Sinnis
Journal:  J Biol Chem       Date:  2001-05-14       Impact factor: 5.157

4.  Green fluorescent protein as a marker in Plasmodium berghei transformation.

Authors:  A A Sultan; V Thathy; V Nussenzweig; R Ménard
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Identification, cloning, expression, and characterization of the gene for Plasmodium knowlesi surface protein containing an altered thrombospondin repeat domain.

Authors:  Babita Mahajan; Dewal Jani; Rana Chattopadhyay; Rana Nagarkatti; Hong Zheng; Victoria Majam; Walter Weiss; Sanjai Kumar; Dharmendar Rathore
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.

Authors:  Deepa Jethwaney; Timothy Lepore; Saria Hassan; Kerrianne Mello; Radha Rangarajan; Willi Jahnen-Dechent; Dyann Wirth; Ali A Sultan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica.

Authors:  Reinhard Schwartz-Albiez; Yvonne Adams; Claus-W von der Lieth; Petra Mischnick; Katherine T Andrews; Michael Kirschfink
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

8.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

Authors:  P Ray; N Sahoo; B Singh; F A Kironde
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.

Authors:  S Chatterjee; M Wery; P Sharma; V S Chauhan
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 10.  Protein-glycosaminoglycan interactions: infectiological aspects.

Authors:  D Sawitzky
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.